ICD-10-PCS › 3
ICD-10-PCS codes starting with 3
1,516 codes, page 8 of 16. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| 3E09XNZ | Introduction of Analgesics, Hypnotics, Sedatives into Nose, External Approach | Valid |
| 3E09XTZ | Introduction of Destructive Agent into Nose, External Approach | Valid |
| 3E0A305 | Introduction of Other Antineoplastic into Bone Marrow, Percutaneous Approach | Valid |
| 3E0A30M | Introduction of Antineoplastic, Monoclonal Antibody, into Bone Marrow, Percutaneous Approach | Valid |
| 3E0A3GC | Introduction of Other Therapeutic Substance into Bone Marrow, Percutaneous Approach | Valid |
| 3E0B304 | Introduction of Liquid Brachytherapy Radioisotope into Ear, Percutaneous Approach | Valid |
| 3E0B305 | Introduction of Other Antineoplastic into Ear, Percutaneous Approach | Valid |
| 3E0B30M | Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Percutaneous Approach | Valid |
| 3E0B328 | Introduction of Oxazolidinones into Ear, Percutaneous Approach | Valid |
| 3E0B329 | Introduction of Other Anti-infective into Ear, Percutaneous Approach | Valid |
| 3E0B33Z | Introduction of Anti-inflammatory into Ear, Percutaneous Approach | Valid |
| 3E0B3BZ | Introduction of Anesthetic Agent into Ear, Percutaneous Approach | Valid |
| 3E0B3GC | Introduction of Other Therapeutic Substance into Ear, Percutaneous Approach | Valid |
| 3E0B3HZ | Introduction of Radioactive Substance into Ear, Percutaneous Approach | Valid |
| 3E0B3KZ | Introduction of Other Diagnostic Substance into Ear, Percutaneous Approach | Valid |
| 3E0B3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Ear, Percutaneous Approach | Valid |
| 3E0B3TZ | Introduction of Destructive Agent into Ear, Percutaneous Approach | Valid |
| 3E0B704 | Introduction of Liquid Brachytherapy Radioisotope into Ear, Via Natural or Artificial Opening | Valid |
| 3E0B705 | Introduction of Other Antineoplastic into Ear, Via Natural or Artificial Opening | Valid |
| 3E0B70M | Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Via Natural or Artificial Opening | Valid |
| 3E0B728 | Introduction of Oxazolidinones into Ear, Via Natural or Artificial Opening | Valid |
| 3E0B729 | Introduction of Other Anti-infective into Ear, Via Natural or Artificial Opening | Valid |
| 3E0B73Z | Introduction of Anti-inflammatory into Ear, Via Natural or Artificial Opening | Valid |
| 3E0B7BZ | Introduction of Anesthetic Agent into Ear, Via Natural or Artificial Opening | Valid |
| 3E0B7GC | Introduction of Other Therapeutic Substance into Ear, Via Natural or Artificial Opening | Valid |
| 3E0B7HZ | Introduction of Radioactive Substance into Ear, Via Natural or Artificial Opening | Valid |
| 3E0B7KZ | Introduction of Other Diagnostic Substance into Ear, Via Natural or Artificial Opening | Valid |
| 3E0B7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Ear, Via Natural or Artificial Opening | Valid |
| 3E0B7TZ | Introduction of Destructive Agent into Ear, Via Natural or Artificial Opening | Valid |
| 3E0BX04 | Introduction of Liquid Brachytherapy Radioisotope into Ear, External Approach | Valid |
| 3E0BX05 | Introduction of Other Antineoplastic into Ear, External Approach | Valid |
| 3E0BX0M | Introduction of Antineoplastic, Monoclonal Antibody, into Ear, External Approach | Valid |
| 3E0BX28 | Introduction of Oxazolidinones into Ear, External Approach | Valid |
| 3E0BX29 | Introduction of Other Anti-infective into Ear, External Approach | Valid |
| 3E0BX3Z | Introduction of Anti-inflammatory into Ear, External Approach | Valid |
| 3E0BXBZ | Introduction of Anesthetic Agent into Ear, External Approach | Valid |
| 3E0BXGC | Introduction of Other Therapeutic Substance into Ear, External Approach | Valid |
| 3E0BXHZ | Introduction of Radioactive Substance into Ear, External Approach | Valid |
| 3E0BXKZ | Introduction of Other Diagnostic Substance into Ear, External Approach | Valid |
| 3E0BXNZ | Introduction of Analgesics, Hypnotics, Sedatives into Ear, External Approach | Valid |
| 3E0BXTZ | Introduction of Destructive Agent into Ear, External Approach | Valid |
| 3E0C304 | Introduction of Liquid Brachytherapy Radioisotope into Eye, Percutaneous Approach | Valid |
| 3E0C305 | Introduction of Other Antineoplastic into Eye, Percutaneous Approach | Valid |
| 3E0C30M | Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Percutaneous Approach | Valid |
| 3E0C328 | Introduction of Oxazolidinones into Eye, Percutaneous Approach | Valid |
| 3E0C329 | Introduction of Other Anti-infective into Eye, Percutaneous Approach | Valid |
| 3E0C33Z | Introduction of Anti-inflammatory into Eye, Percutaneous Approach | Valid |
| 3E0C3BZ | Introduction of Anesthetic Agent into Eye, Percutaneous Approach | Valid |
| 3E0C3GC | Introduction of Other Therapeutic Substance into Eye, Percutaneous Approach | Valid |
| 3E0C3HZ | Introduction of Radioactive Substance into Eye, Percutaneous Approach | Valid |
| 3E0C3KZ | Introduction of Other Diagnostic Substance into Eye, Percutaneous Approach | Valid |
| 3E0C3MZ | Introduction of Pigment into Eye, Percutaneous Approach | Valid |
| 3E0C3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Eye, Percutaneous Approach | Valid |
| 3E0C3SF | Introduction of Other Gas into Eye, Percutaneous Approach | Valid |
| 3E0C3TZ | Introduction of Destructive Agent into Eye, Percutaneous Approach | Valid |
| 3E0C704 | Introduction of Liquid Brachytherapy Radioisotope into Eye, Via Natural or Artificial Opening | Valid |
| 3E0C705 | Introduction of Other Antineoplastic into Eye, Via Natural or Artificial Opening | Valid |
| 3E0C70M | Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Via Natural or Artificial Opening | Valid |
| 3E0C728 | Introduction of Oxazolidinones into Eye, Via Natural or Artificial Opening | Valid |
| 3E0C729 | Introduction of Other Anti-infective into Eye, Via Natural or Artificial Opening | Valid |
| 3E0C73Z | Introduction of Anti-inflammatory into Eye, Via Natural or Artificial Opening | Valid |
| 3E0C7BZ | Introduction of Anesthetic Agent into Eye, Via Natural or Artificial Opening | Valid |
| 3E0C7GC | Introduction of Other Therapeutic Substance into Eye, Via Natural or Artificial Opening | Valid |
| 3E0C7HZ | Introduction of Radioactive Substance into Eye, Via Natural or Artificial Opening | Valid |
| 3E0C7KZ | Introduction of Other Diagnostic Substance into Eye, Via Natural or Artificial Opening | Valid |
| 3E0C7MZ | Introduction of Pigment into Eye, Via Natural or Artificial Opening | Valid |
| 3E0C7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Eye, Via Natural or Artificial Opening | Valid |
| 3E0C7SF | Introduction of Other Gas into Eye, Via Natural or Artificial Opening | Valid |
| 3E0C7TZ | Introduction of Destructive Agent into Eye, Via Natural or Artificial Opening | Valid |
| 3E0CX04 | Introduction of Liquid Brachytherapy Radioisotope into Eye, External Approach | Valid |
| 3E0CX05 | Introduction of Other Antineoplastic into Eye, External Approach | Valid |
| 3E0CX0M | Introduction of Antineoplastic, Monoclonal Antibody, into Eye, External Approach | Valid |
| 3E0CX28 | Introduction of Oxazolidinones into Eye, External Approach | Valid |
| 3E0CX29 | Introduction of Other Anti-infective into Eye, External Approach | Valid |
| 3E0CX3Z | Introduction of Anti-inflammatory into Eye, External Approach | Valid |
| 3E0CXBZ | Introduction of Anesthetic Agent into Eye, External Approach | Valid |
| 3E0CXGC | Introduction of Other Therapeutic Substance into Eye, External Approach | Valid |
| 3E0CXHZ | Introduction of Radioactive Substance into Eye, External Approach | Valid |
| 3E0CXKZ | Introduction of Other Diagnostic Substance into Eye, External Approach | Valid |
| 3E0CXMZ | Introduction of Pigment into Eye, External Approach | Valid |
| 3E0CXNZ | Introduction of Analgesics, Hypnotics, Sedatives into Eye, External Approach | Valid |
| 3E0CXSF | Introduction of Other Gas into Eye, External Approach | Valid |
| 3E0CXTZ | Introduction of Destructive Agent into Eye, External Approach | Valid |
| 3E0D304 | Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D305 | Introduction of Other Antineoplastic into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D30M | Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D328 | Introduction of Oxazolidinones into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D329 | Introduction of Other Anti-infective into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D33Z | Introduction of Anti-inflammatory into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D34Z | Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D36Z | Introduction of Nutritional Substance into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D37Z | Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D3BZ | Introduction of Anesthetic Agent into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D3GC | Introduction of Other Therapeutic Substance into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D3HZ | Introduction of Radioactive Substance into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D3KZ | Introduction of Other Diagnostic Substance into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D3RZ | Introduction of Antiarrhythmic into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D3TZ | Introduction of Destructive Agent into Mouth and Pharynx, Percutaneous Approach | Valid |
| 3E0D704 | Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, Via Natural or Artificial Opening | Valid |